Association between interleukin 6 promoter variants and chronic hepatitis B progression

Experimental and Molecular Medicine

Volumn 35, Issue 2, 2003, Pages 76-82

  Park, Byung Lae ^a   Lee, Hyo Suk ^b   Kim, Yoon Jun ^b   Kim, Jun Yeon ^a   Jung, Ji Hyun ^a   Kim, Lyoung Hyo ^a   Shin, Hyoung Doo ^a  

^a SNP Genetics Inc   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

Author keywords

Carcinoma; Haplotypes; Hepatitis B virus; Hepatocellular; Interleukin 6; Polymorphism, single nucleotide; Promoter regions (genetics)

Indexed keywords

INTERLEUKIN 6;

ADULT; ARTICLE; CHRONIC HEPATITIS; DISEASE COURSE; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HEPATITIS B; HETEROZYGOTE; HOMOZYGOTE; HUMAN; IMMUNE RESPONSE; IMMUNOREGULATION; KOREA; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PORTAL HYPERTENSION; PROMOTER REGION; RECURRENCE RISK; SINGLE NUCLEOTIDE POLYMORPHISM;

HEPATITIS B VIRUS;

EID: 0038147057     PISSN: 12263613     EISSN: 20926413     Source Type: Journal    
DOI: 10.1038/emm.2003.11     Document Type: Article

References (38)

1. Almarri A, Batchelor JR. HLA and hepatitis B infection. Lancet 1994;344(8931):1194-5
2. Bellamy R, Ruwende C, Corrah T, McAdam KP, Thursz M, Whittle HC, Hill AV. Tuberculosis and chronic hepatitis B virus infection in Africans and variation in the vitamin D receptor gene. J Infect Dis 1999;179(3):721-4
3. Blumberg BS. Hepatitis B virus and the control of hepatocellular carcinoma. IARC Sci Publ 1984;63:243-61
4. Brull DJ, Montgomery HE, Sanders J, Dhamrait S, Luong L, Rumley A, Lowe GD, Humphries SE. Interleukin-6 gene -174 G > C and -572 G > C promoter polymorphisms are strong predictors of plasma interleukin-6 levels after coronary artery bypass surgery. Arterioscler Thromb Vasc Biol 2001; 21(9):1458-63
5. Burzotta F, Iacoviello L, Di Castelnuovo A, Glieca F, Luciani N, Zamparelli R, Schiavello R, Donati MB, Maseri A, Possati G, Andreotti F. Relation of the -174 G/C polymorphism of interleukin-6 to interleukin-6 plasma levels and to length of hospitalization after surgical coronary revascularization. Am J Cardiol 2001;88(10):1125-8
6. Cacciola I, Cerenzia G, Pollicino T, Squadrito G, Castellaneta S, Zanetti AR, Mieli-Vergani G, et al. Genomic heterogeneity of hepatitis B virus (HBV) and outcome of perinatal HBV infection. J Hepatol 2002;36:426-32
7. Cavet J, Dickinson AM, Norden J, Taylor PR, Jackson GH, Middleton PG. Interferon-gamma and interleukin-6 gene polymorphisms associate with graft-versus-host disease in HLA-matched sibling bone marrow transplantation. Blood 2001; 98(5):1594-600
8. Cox ED, Hoffmann SC, DiMercurio BS, Wesley RA, Harlan DM, Kirk AD, Blair PJ. Cytokine polymorphic analyses indicate ethnic differences in the allelic distribution of interleukin-2 and interleukin-6. Transplantation 2001;72(4):720-6
9. Cruz AC, Frentzen BH, Behnke M. Hepatitis B: A case for prenatal screening of all patients. Am J Obstet Gynecol 1987;156(5):1180-3
10. Don RH, Cox PT, Wainwright BJ, Baker K, Mattick JS. 'Touchdown' PCR to circumvent spurious priming during gene amplification. Nucleic Acids Res 1991;19(14):4008
11. Fedetz M, Matesanz F, Pascual M, Martin J, Fernandez O, Guerrero M, Alcina A. The -174/-597 promoter polymorphisms in the interleukin-6 gene are not associated with susceptibility to multiple sclerosis. J Neurol Sci 2001; 190(1-2):69-72
12. Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, Yudkin JS, Humphries S, Woo P. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 1998;102(7):1369-76
13. Galun E, Nahor O, Eid A, Jurim O, Rose-John S, Blum HE, Nussbaum O, Ilan E, Daudi N, Shouval D, Reisner Y, Dagan S. Human interleukin-6 facilitates hepatitis B virus infection in vitro and in vivo. Virology 2000;270(2):299-309
14. Hedrick PW. Gametic disequilibrium measures: proceed with caution. Genetics 1987;117(2):331-41
15. Helmy N, Maly FE, Bestmann L. Detection of the single-base substitution -174 G→C in the interleukin-6 gene by real-time polymerase chain reaction: comment on the article by Moos et al. Arthritis Rheum 2001;44(9):2213-4
16. Huh K, Choi SY, Whang YS, Lee DS. Prevalence of viral hepatitis markers in Korean patients with hepatocellular carcinoma. J Korean Med Sci 1998;13(3):306-10
17. Kakumu S, Shinagawa T, Ishikawa T, Yoshioka K, Wakita T, Ida N. Interleukin 6 production by peripheral blood mononuclear cells in patients with chronic hepatitis B virus infection and primary biliary cirrhosis. Gastroenterol Jpn 1993;28(1):18-24
18. Lee HS, Han CJ, Kim CY. Predominant etiologic association of hepatitis C virus with hepatocellular carcinoma compared with hepatitis B virus in elderly patients in a hepatitis B-endemic area. Cancer 1993;72:2564-7
19. Lee Y, Park US, Choi I, Yoon SK, Park YM, Lee YI. Human interleukin 6 gene is activated by hepatitis B virus-X protein in human hepatoma cells. Clin Cancer Res 1998;4(7):1711-7
20. Malaguarnera M, Di Fazio I, Laurino A, Ferlito L, Romano M, Trovato BA. Serum interleukin 6 concentrations in chronic hepatitis C patients before and after interferon-alpha treatment. Int J Clin Pharmacol Ther 1997;35(9):385-8
21. Merican I, Guan R, Amarapuka D, Alexander MJ, Chutaputti A, Chien RN, Hasnian SS, Leung N, Lesmana L, Phiet PH, Sjalfoellah Noer HM, Sollano J, Sun HS, Xu DZ. Chronic hepatitis B virus infection in Asian countries. J Gastroenterol Hepatol 2000;15(12):1356-61
22. Ota N, Nakajima T, Nakazawa I, Suzuki T, Hosoi T, Orimo H, Inoue S, Shirai Y, Emi M. A nucleotide variant in the promoter region of the interleukin-6 gene associated with decreased bone mineral density. J Hum Genet 2001;46(5): 267-72
23. Oyanagi Y, Takahashi T, Matsui S, Takahashi S, Boku S, Takahashi K, Furukawa K, Arai F, Asakura H. Enhanced expression of interleukin-6 in chronic hepatitis C. Liver 1999;19(6):464-72
24. Parra EJ, Marcini A, Akey J, Martinson J, Batzer MA, Cooper R, Forrester T, Allison DB, Deka R, Ferrell RE, Shriver MD. Estimating African American admixture proportions by use of population-specific alleles. Am J Hum Genet 1998;63(6): 1839-51
25. Rannala B, Reeve JP. High-resolution multipoint linkage-disequilibrium mapping in the context of a human genome sequence. Am J Hum Genet 2001;69(1):159-78
26. Riley JH, Allan CJ, Lai E, Roses A. The use of single nucleotide polymorphisms in the isolation of common disease genes. Pharmacogenomics 2000;1(1):39-47
27. Sekiyama KD, Yoshiba M, Thomson AW. Circulating proinflammatory cytokines (IL-1 beta, TNF-alpha, and IL-6) and IL-1 receptor antagonist (IL-1Ra) in fulminant hepatic failure and acute hepatitis. Clin Exp Immunol 1994;98(1):71-7
28. Shimbo S, Zhang ZW, Qu JB, Wang JJ, Zhang CL, Song LH, Watanabe T, Higashikawa K, Ikeda M. Urban-rural comparison of HBV and HCV infection prevalence among adult women in Shandong Province, China. Southeast Asian J Trop Med Public Health 1997;28(3):500-6
29. Song W, Zhang F, Li Z. A quantitative analysis of IL-6 mRNA expression of peripheral blood monocyte cell in patients with chronic hepatitis B. Zhonghua Gan Zang Bing Za Zhi 2000;8(6):346-7
30. Stephens JC, Schneider JA, Tanguay DA, Choi J, Acharya T, Stanley SE, Jiang R, Messer CJ, Chew A, Han JH, Duan J, Carr JL, Lee MS, Koshy B, Kumar AM, Zhang G, Newell WR, Windemuth A, Xu C, Kalbfleisch TS, Shaner SL, Arnold K, Schulz V, Drysdale CM, Nandabalan K, Judson RS, Ruano G, Vovis GF. Haplotype variation and linkage disequilibrium in 313 human genes. Science 2001;293(5529): 489-93
31. Terry CF, Loukaci V, Green FR. Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation. J Biol Chem 2000;275(24):18138-44
32. Thursz M. Genetic susceptibility in chronic viral hepatitis. Antiviral Res 2001;52(2):113-6
33. Thursz MR. Host genetic factors influencing the outcome of hepatitis. J Viral Hepat 1997;4(4):215-20
34. Wang JY, Wang XL, Liu P. Detection of serum TNF-alpha, IFN-beta, IL-6 and IL-8 in patients with hepatitis B. World J Gastroenterol 1999;5(1):38-40
35. Yu H, Harris RE, Kapat GC, et al. Cigarette smoking, alcohol consumption, and primary liver cancer: A case-control study in the USA. Int J Cancer 1988;42:325-8
36. Yu MC, Yuan JM, Govindarajan S, Ross RK. Epidemiology of hepatocellular carcinoma. Can J Gastroenterol 2000a; 14(8):703-9
37. Yu MW, Pai Cl, Yang SY, Hsiao TJ, Chang HC, Lin SM, Liaw YF, Chen PJ, Chen CJ. Role of N-acetyltransferase polymorphisms in hepatitis B related hepatocellular carcinoma: impact of smoking on risk. Gut 2000b;47(5):703-9
38. Zhai R, Liu G, Yang C, Huang C, Wu C, Christiani DC. The G to C polymorphism at -174 of the interleukin-6 gene is rare in a Southern Chinese population. Pharmacogenetics 2001;11(8):699-701